Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PSOCADIA: Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis

NCT04950218 is registered in ClinicalTrials.gov with Herlev and Gentofte Hospital as lead sponsor.

NCT NCT04950218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04950218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PSOCADIA: Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis
Lead sponsor
Herlev and Gentofte Hospital
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2021
Completion date
October 1, 2034
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, cardiovascular pathology, cardiovascular risk factor, heart diseases, heart failure, heart failure, diastolic, heart failure, systolic, left ventricular dysfunction, myocardial infarction, myocardial ischemia, psoriasis, psoriasis annularis, psoriasis circinata, psoriasis diffusa, psoriasis face, psoriasis geographica, psoriasis guttate, psoriasis gyrata, psoriasis palmaris, psoriasis plantaris, psoriasis universalis, psoriasis vulgaris, psoriatic nail, stroke